TUFANO, ANTONELLA
 Distribuzione geografica
Continente #
AS - Asia 7.643
NA - Nord America 5.328
EU - Europa 4.186
SA - Sud America 892
Continente sconosciuto - Info sul continente non disponibili 339
AF - Africa 213
OC - Oceania 5
Totale 18.606
Nazione #
US - Stati Uniti d'America 5.080
SG - Singapore 3.525
RU - Federazione Russa 1.953
CN - Cina 1.465
VN - Vietnam 1.232
BR - Brasile 697
IT - Italia 653
HK - Hong Kong 561
DE - Germania 552
FR - Francia 235
NL - Olanda 152
BD - Bangladesh 144
GB - Regno Unito 138
IN - India 132
JP - Giappone 129
CA - Canada 125
FI - Finlandia 117
KR - Corea 116
CI - Costa d'Avorio 71
ES - Italia 64
IE - Irlanda 64
UA - Ucraina 64
AR - Argentina 61
MX - Messico 57
IQ - Iraq 48
AT - Austria 43
PH - Filippine 42
ZA - Sudafrica 42
ID - Indonesia 36
PL - Polonia 35
EC - Ecuador 31
TW - Taiwan 27
SE - Svezia 26
TH - Thailandia 26
CO - Colombia 25
PK - Pakistan 23
VE - Venezuela 22
CL - Cile 21
MA - Marocco 19
PY - Paraguay 15
SA - Arabia Saudita 14
JM - Giamaica 13
JO - Giordania 13
AE - Emirati Arabi Uniti 12
TR - Turchia 12
CH - Svizzera 11
BE - Belgio 10
DZ - Algeria 10
EG - Egitto 10
KE - Kenya 10
PE - Perù 10
TT - Trinidad e Tobago 10
NI - Nicaragua 9
NP - Nepal 9
BG - Bulgaria 8
CZ - Repubblica Ceca 8
IL - Israele 8
LT - Lituania 8
TN - Tunisia 8
HN - Honduras 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
CR - Costa Rica 6
MY - Malesia 6
OM - Oman 6
SK - Slovacchia (Repubblica Slovacca) 6
BO - Bolivia 5
BW - Botswana 5
CG - Congo 5
GE - Georgia 5
GR - Grecia 5
GT - Guatemala 5
LB - Libano 5
MD - Moldavia 5
PA - Panama 5
PS - Palestinian Territory 5
UY - Uruguay 5
AL - Albania 4
AO - Angola 4
ET - Etiopia 4
LV - Lettonia 4
AU - Australia 3
CD - Congo 3
DK - Danimarca 3
KH - Cambogia 3
KZ - Kazakistan 3
MN - Mongolia 3
NG - Nigeria 3
PT - Portogallo 3
RO - Romania 3
YE - Yemen 3
AM - Armenia 2
BB - Barbados 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GA - Gabon 2
HT - Haiti 2
IR - Iran 2
KG - Kirghizistan 2
LK - Sri Lanka 2
Totale 18.224
Città #
Singapore 1.716
San Jose 982
Hefei 571
Hong Kong 533
Ashburn 464
Moscow 462
Ho Chi Minh City 341
Santa Clara 338
Beijing 306
Hanoi 298
Chandler 213
The Dalles 199
Naples 166
Los Angeles 158
Lauterbourg 156
Amsterdam 125
Millbury 124
Tokyo 111
Seoul 105
New York 98
Buffalo 83
São Paulo 81
Redondo Beach 80
Boston 69
Dallas 69
Princeton 68
Da Nang 64
Munich 60
Nuremberg 58
Haiphong 51
Chicago 49
Nanjing 49
Frankfurt am Main 48
Milan 47
Orem 47
Council Bluffs 43
Chennai 42
Lawrence 41
Denver 39
Krefeld 38
London 38
Des Moines 36
Seattle 34
Wilmington 34
Ottawa 33
Boardman 32
Rome 32
Montreal 30
Brooklyn 29
Jacksonville 29
Turku 27
Warsaw 26
Mexico City 25
Atlanta 23
Toronto 23
Baghdad 22
Helsinki 22
Napoli 22
Stockholm 22
Phoenix 20
Rio de Janeiro 20
Biên Hòa 18
Castellón 18
Johannesburg 18
Manchester 18
Norwalk 18
Poplar 18
Vienna 18
Düsseldorf 17
Hải Dương 17
Belo Horizonte 16
Houston 16
Mykolayiv 16
San Francisco 16
Brasília 15
Kronberg 15
Bologna 14
Nanchang 14
Santiago 14
Ann Arbor 13
Bangkok 13
Changsha 13
Dhaka 13
Hebei 13
Jiaxing 13
Kochi 13
Thái Bình 13
Amman 12
Bắc Ninh 12
Campinas 12
Curitiba 12
Dublin 12
Falkenstein 12
New Delhi 12
Phủ Lý 12
Tettnang 12
Woodbridge 12
Basel 11
Can Tho 11
Florence 10
Totale 9.723
Nome #
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 232
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 227
Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry 218
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 197
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 195
Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation 162
Budd-Chiari syndrome in a paroxysmal nocturnal hemoglobinuria patient with previous cerebral venous thrombosis 162
Spontaneous Muscle Hematoma in Patients with COVID-19: A Systematic Literature Review with Description of an Additional Case Series 159
Cyclic supplementation of 5-MTHF is effective for the correction of hyperhomocysteinemia 156
Use of oral anti-Xa inhibitor in prosthetic mechanical aortic valve with warfarin hypersensitivity due to the FIX p.(Ala37Thr) pro peptide variant: case report and literature review. 151
Long-term anticoagulant therapy of patients with venous thromboembolism. What are the practices? 147
Challenging report of cardiopulmonary bypass in 16th week pregnant patient with endoventricular mass 147
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study 146
Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism 143
Fondaparinux in the initial and long-term treatment of venous thromboembolism 140
Long-lasting intestinal bleeding in an old patient with multiple mucosal vascular abnormalities and Glanzmann's thrombasthenia: 3-year pharmacological management. 140
Predictors of active cancer thromboembolic outcomes: RIETE experience of the Khorana score in cancer-associated thrombosis 138
“A fast and accurate method for genotyping the Angiotensin-Converting Enzyme (ACE) I/D polymorphism” 137
Right-to-left shunt, atrial septal aneurysm and thrombophilia in patients with cryptogenic stroke or TIA vs. those with venous thrombo-embolism 134
First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry 132
Plasma homocysteine and its determinants in diabetic retinopathy 132
Inferior Vena Cava Agenesis and Deep Vein Thrombosis in the Young: A Review of the Literature and Local Experience 130
Efficacy and safety of direct oral anticoagulants in splanchnic vein thrombosis: a pooled analysis of literature studies 130
Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy 129
Corrigendum: The new Italian registry of infantile thrombosis (RITI): a reflection on its journey, challenges and pitfalls 128
Risk factors and recurrent thrombotic episodes in patients with cerebral venous thrombosis 128
Acquired Factor v Inhibitor after Coronavirus Disease 2019 (COVID-19) 128
A Rare Case of Tricuspid Valve Libman-Sacks Endocarditis in a Pregnant Woman with Primary Antiphospholipid Syndrome 127
Three-dimensional echocardiographic evaluation of the right ventricle in patients with uncomplicated systemic lupus erythematosus 127
Acquired haemophilia a in the elderly: case reports. 125
The infectious burden in atherothrombosis. 125
Preventing postsurgical venous thromboembolism: pharmacological approaches 125
Oxidative stress and plateletactivation in homozygous homocystinuria 124
The challenge of diagnosing pulmonary embolism in children, pregnant women, and elderly patients: a descriptive review of the literature. 124
Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. 124
Plasma homocysteine and microvascular complications in type 1 diabetes. 124
The new Italian registry of infantile thrombosis (RITI): A reflection on its journey, challenges and pitfalls. 123
Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry 122
The role of cardiovascular ultrasound in diagnosis and management of pulmonary embolism 122
The impact of risk-adjusted heparin regimens on the outcome of patients with covid-19 infection. A prospective cohort study 122
Venous thromboembolism in covid-19 compared to non-covid-19 cohorts: A systematic review with meta-analysis 122
Development of a Risk Prediction Score for Occult Cancer in Patients With VTE 121
Paediatric arterial ischaemic stroke and cerebral sinovenous thrombosis: First report from the italian registry of pediatric thrombosis (R. I. T. I., Registro Italiano Trombosi Infantili) 121
Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review 120
Acute coronary syndrome and severe haemophilia: an unusual association with challenging treatment. 120
Cardiovascular disease and antiphospholipid syndrome: how to predict and how to treat? 120
Fatal events in cancer patients receiving anticoagulant therapy for venous thromboembolism 119
ANMCO Position Paper: Long-term follow-up of patients with pulmonary thromboembolism 119
Cardiac Manifestations of Antiphospholipid Syndrome: Clinical Presentation, Role of Cardiac Imaging, and Treatment Strategies 119
The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients 119
Venous thromboembolism and major bleeding in severe and critical COVID-19 hospitalized patients 119
A fast and accurate method for genotyping the angiotensin-converting enzyme I/D polymorphism. 118
The hla variant rs6903608 is associated with disease onset and relapse of immune-mediated thrombotic thrombocytopenic purpura in caucasians 118
Cytomegalovirus-Associated Splanchnic Vein Thrombosis in Immunocompetent Patients: Two Case Reports and Literature Review 117
Predisposing factors in patients with early-onset cerebral vein thrombosis 117
Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies 117
A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the upper extremity 117
HELLP syndrome and its relation with the antiphospholipid syndrome. 117
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications 116
Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature. 115
Early use of echocardiography in patients with acute pulmonary embolism: Findings from the RIETE registry 114
Pharmacokinetic Studies, Assessing the Efficiency of FVIII/VWF Concentrates and Intravenous Human Immunoglobulin, Revealed the Etiopathogenesis of Acquired von Willebrand Disease in Patient With MGUS 114
Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study 114
Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project 113
[Absence of an association of the D allele of the ACE gene with arterial pressure in mild-moderate essential arterial hypertension]. 113
A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the lower limbs 112
Diabetes mellitus and cardiovascular prevention: the role and the limitations of currently available antiplatelet drugs. 110
Speckle tracking echocardiography in patients with systemic lupus erythematosus: A meta-analysis 110
The first ambulatory screening on thromboembolism: a multicentre, cross-sectional, observational study on risk factors for venous thromboembolism. 109
Immunochip analysis identifies novel susceptibility loci in the human leukocyte antigen region for acquired thrombotic thrombocytopenic purpura 108
Arterial Thrombosis in Cancer Patients: An Update 108
Sex differences in patients receiving anticoagulant therapy for venous thromboembolism 107
Venous thromboembolism: which patients are truly at risk? 107
Management of isolated distal deep–vein thrombosis with direct oral anticoagulants in the RIETE registry 106
Ensuring medication adherence with direct oral anticoagulant drugs: lessons from adherence with vitamin K antagonists (VKAs). 106
Anticancer Drug-Related Nonvalvular Atrial Fibrillation: Challenges in Management and Antithrombotic Strategies 106
Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis 106
Low Rate of Intrahospital Deep Venous Thrombosis in Acutely Ill Medical Patients: Results From the AURELIO Study 105
Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism 105
The "antiphospholipid triangle" in an asymptomatic patient: a case report. 105
Left ventricular diastolic abnormalities other than valvular heart disease in antiphospholipid syndrome: An echocardiographic study 105
Atrial Fibrillation, Cancer and Echocardiography 105
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry. 104
Aspirin for preventing the recurrence of venous thromboembolism. 104
Non-O blood group as a risk factor for cerebral vein thrombosis 103
A novel mutation in the fibrinogen γ-chain gene c.952G>T, p. (Gly318Cys) leading to hypo dysfibrinogenemia 102
Molecular analysis and genotype-phenotype correlation in patients with antithrombin deficiency from Southern Italy. 101
Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism 101
Use of heparin preparations in older patients 100
Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism 100
Simulation-Based Education for Physicians to Increase Oral Anticoagulants in Hospitalized Elderly Patients with Atrial Fibrillation 100
Venous thromboembolism in patients immobilised at home 99
Noninvasive assessment of liver fibrosis in patients with chronic hepatitis C (and congenital bleeding disorders): where do we stand? 99
Acquired Inhibitors of coagulation factors: Part I-acquired hemophilia a 99
DVT Management and Outcome Trends, 2001 to 2014 98
Rate and predictors of thromboprophylaxis in internal medicine wards: Results from the AURELIO study. 96
Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism 95
The thromboembolic risk in giant cell arteritis: A critical review of the literature 95
The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site 94
Italian intersociety consensus on DOAC use in internal medicine 92
Totale 12.323
Categoria #
all - tutte 62.350
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.350


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022667 0 1 3 0 3 4 19 10 132 85 134 276
2022/2023895 145 66 13 29 57 65 0 173 178 106 52 11
2023/2024841 29 105 144 49 34 14 11 120 58 22 159 96
2024/20254.968 236 323 24 67 139 281 484 309 503 490 1.668 444
2025/202610.287 1.053 972 1.062 1.142 1.704 433 997 583 1.232 624 292 193
2026/2027299 242 57 0 0 0 0 0 0 0 0 0 0
Totale 18.606